Breaking News

Takeda, Resolve in Autoimmune Pact

February 28, 2013

To develop compounds for the treatment of lupus

Takeda Pharmaceutical Co. Ltd. and Resolve Therpeutics have entered into a partnership to develop compounds for the treatment of lupus and other autoimmune diseases. The lead compound, RSLV-132, a novel nuclease Fc fusion protein, will begin clinical development later this year. Resolve has additional candidates in preclinical development that target autoantibody-containing immune complexes, which are thought to be the most frequent trigger of lupus.
 
Resolve will conduct all development work through the first RSLV-132 Phase Ib/IIa trial, after which Takeda has the exclusive option to license the lead compound and all other compounds from the Resolve platform. Takeda would then assume lead responsibility for worldwide development and commercialization. Takeda will contribute funding for continued development of RSLV-132 through an initial payment of $8 million. Upon exercising its option, Takeda would pay Resolve an option fee plus additional development milestones totaling $247 million, as well as royalties on product sales.
 
"This collaboration with Resolve is very exciting as its innovative pipeline of nuclease fusion proteins has the potential to provide a new approach to helping lupus patients," said Tetsuyuki Maruyama, Ph.D., general manager of the Pharmaceutical Research Division at Takeda.
 
"We are delighted to begin work with our Takeda colleagues," said James Posada, Ph.D., MBA, chief executive officer of Resolve. "We feel strongly that Takeda's expertise, commitment to inflammation, and considerable resources will give the Resolve compounds the best possible chance of success."

Related Contract Manufacturing:

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Filings Update

    Filings Update

    December 1, 2015
    Roche, Pfizer, Janssen, BMS and more